Limited global diversity of the Plasmodium vivax merozoite surface protein 4 gene

Infection, Genetics and Evolution

Volumn 9, Issue 5, 2009, Pages 821-826

  Putaporntip, Chaturong ^a   Jongwutiwes, Somchai ^a   Ferreira, Marcelo U ^b   Kanbara, Hiroji ^c   Udomsangpetch, Rachanee ^d   Cui, Liwang ^e  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c NAGASAKI UNIVERSITY   (Japan)

^d Mahidol University   (Thailand)

^e PENNSYLVANIA STATE UNIVERSITY   (United States)

Author keywords

Genetic diversity; Merozoite surface protein; Plasmodium vivax; Population differentiation; Selection

Indexed keywords

AMINO ACID DERIVATIVE; MEMBRANE PROTEIN; MEROZOITE SURFACE PROTEIN 4; NUCLEOTIDE; TETRAPEPTIDE; UNCLASSIFIED DRUG;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; EXON; GENETIC CONSERVATION; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HAPLOTYPE; MEROZOITE; NONHUMAN; NUCLEOTIDE SEQUENCE; PLASMODIUM VIVAX; POPULATION GENETICS; PRIORITY JOURNAL; PROTEIN PURIFICATION; SINGLE NUCLEOTIDE POLYMORPHISM; THAILAND;

AMINO ACID SUBSTITUTION; ANIMALS; ANTIGENS, PROTOZOAN; HUMANS; LINKAGE DISEQUILIBRIUM; MALARIA, VIVAX; PLASMODIUM VIVAX; POLYMORPHISM, GENETIC; PROTOZOAN PROTEINS; SELECTION (GENETICS); SEQUENCE ALIGNMENT;

PLASMODIUM VIVAX;

EID: 67749132432     PISSN: 15671348     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.meegid.2009.04.017     Document Type: Article

References (42)

1. Baird J.K. Neglect of Plasmodium vivax malaria. Trends Parasitol. 23 (2007) 533-539
2. Barcus M.J., Basri H., Picarima H., Manyakori C., Sekartuti, Elyazar I., Bangs M.J., Maguire J.D., and Baird J.K. Demographic risk factors for severe and fatal vivax and falciparum malaria among hospital admissions in northeastern Indonesian Papua. Am. J. Trop. Med. Hyg. 77 (2007) 984-991
3. Benet A., Livingstone T., Reeder J.C., and Cortes A. Diversity of the Plasmodium falciparum vaccine candidate merozoite surface protein 4 (MSP4) in a natural population. Mol. Biochem. Parasitol. 134 (2004) 275-280
4. Black C.G., Barnwell J.W., Huber C.S., Galinski M.R., and Coppel R.L. The Plasmodium vivax homologues of merozoite surface proteins 4 and 5 from Plasmodium falciparum are expressed at different locations in the merozoite. Mol. Biochem. Parasitol. 120 (2002) 215-224
5. Carlton J.M., Adams J.H., Silva J.C., Bidwell S.L., Lorenzi H., Caler E., Crabtree J., Angiuoli S.V., Merino E.F., Amedeo P., Cheng Q., Coulson R.M., Crabb B.S., Del Portillo H.A., Essien K., Feldblyum T.V., Fernandez-Becerra C., Gilson P.R., Gueye A.H., Guo X., Kang'a S., Kooij T.W., Korsinczky M., Meyer E.V., Nene V., Paulsen I., White O., Ralph S.A., Ren Q., Sargeant T.J., Salzberg L., Stoeckert C.J., Sullivan S.A., Yamamoto M.M., Hoffman S.L., Wortman J.R., Gardner M.J., Galinski M.R., Barnwell J.W., and Fraser-Liggett C.M. Comparative genomics of the neglected human malaria parasite Plasmodium vivax. Nature 455 (2008) 757-763
6. Cortes A., Mellombo M., Masciantonio R., Murphy V.J., Reeder J.C., and Anders R.F. Allele specificity of naturally acquired antibody responses against Plasmodium falciparum apical membrane antigen 1. Infect. Immun. 73 (2005) 422-430
7. Cowman A.F., and Crabb B.S. Invasion of red blood cells by malaria parasites. Cell 124 (2006) 755-766
8. Cui L., Escalante A.A., Imwong M., and Snounou G. The genetic diversity of Plasmodium vivax populations. Trends Parasitol. 19 (2003) 220-226
9. Dooland D.L., and Steward V.N. Status of malaria vaccine R&D in 2007. Expert Rev. Vaccines 6 (2007) 903-905
10. Excoffier L., Laval G., and Schneider S. Arlequin ver. 3.0: an integrated software package for population genetics data analysis. Evol. Bioinfor. (2005) 47-50 Online 1
11. Ferreira M.U., Karunaweera N.D., da Silva-Nunes M., da Silva N.S., Wirth D.F., and Hartl D.L. Population structure and transmission dynamics of Plasmodium vivax in rural Amazonia. J. Infect. Dis. 195 (2007) 1218-1226
12. Figtree M., Pasay C.J., Slade R., Cheng Q., Cloonan N., Walker J., and Saul A. Plasmodium vivax synonymous substitution frequencies, evolution and population structure deduced from diversity in AMA 1 and MSP 1 genes. Mol. Biochem. Parasitol. 108 (2000) 53-66
13. Genton B., D'Acremont V., Rare L., Baea K., Reeder J.C., Alpers M.P., and Müller I. Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea. PLoS Med. 5 (2008) e127
14. Gomez A., Suarez C.F., Martinex P., Saravia C., and Patarroyo M.A. High polymorphisms in Plasmodium vivax merozoite surface protein-5 (MSP5). Parasitology 133 (2006) 661-672
15. Goschnick M.W., Black C.G., Kedzierski L., Holder A.A., and Coppel R.L. Merozoite surface protein 4/5 provides protection against lethal challenge with a heterologous malaria parasite strain. Infect. Immun. 72 (2004) 5840-5849
16. Grynberg P., Fontes C.J., Hughes A.L., and Braga E.M. Polymorphism at the apical membrane antigen 1 locus reflects the world population history of Plasmodium vivax. BMC Evol. Biol. 8 (2008) 123
17. Guerra C.A., Snow R.W., and Hay S.I. Mapping the global extent of malaria in 2005. Trends Parasitol. 22 (2006) 353-358
18. Gunasekera A.M., Wickramarachchi T., Neafsey D.E., Ganguli I., Perera L., Premaratne P.H., Hartl D., Handunnetti S.M., Udagama-Randeniya P.V., and Wirth D.F. Genetic diversity and selection at the Plasmodium vivax apical membrane antigen-1 (PvAMA-1) locus in a Sri Lankan population. Mol. Biol. Evol. 24 (2007) 939-947
19. Hay S.I., Guerra C.A., Tatem A.J., Noor A.M., and Snow R.W. The global distribution and population at risk of malaria: past, present, and future. Lancet Infect. Dis. 4 (2004) 327-336
20. Hodder A.N., Crewther P.E., and Anders R.F. Specificity of the protective antibody response to apical membrane antigen 1. Infect. Immun. 69 (2001) 3286-3294
21. Imwong M., Nair S., Pukrittayakamee S., Sudimack D., Williams J.T., Mayxay M., Newton P.N., Kim J.R., Nandy A., Osorio L., Carlton J.M., White N.J., Day N.P., and Anderson T.J. Contrasting genetic structure in Plasmodium vivax populations from Asia and South America. Int. J. Parasitol. 37 (2007) 1013-1022
22. Jongwutiwes S., Putaporntip C., Friedman R., and Hughes A.L. The extent of nucleotide polymorphism is highly variable across a 3-kb region on Plasmodium falciparum chromosome 2. Mol. Biol. Evol. 19 (2002) 1585-1590
23. Karunaweera N.D., Ferreira M.U., Munasinghe A., Barnwell J.W., Collins W.E., King C.L., Kawamoto F., Hartl D.L., and Wirth D.F. Extensive microsatellite diversity in the human malaria parasite Plasmodium vivax. Gene 410 (2008) 105-112
24. Larsen M.V., Lundegaard C., Lamberth K., Buus S., Brunak S., Lund O., and Nielsen M. An integrative approach to CTL epitope prediction: a combined algorithm integrating MHC class I binding, TAP transport efficiency, and proteasomal cleavage predictions. Eur. J. Immunol. 35 (2005) 2295-2303
25. Martinez P., Suarez C.F., Gomez A., Cardenas P.P., Guerrero J.E., and Patarroyo M.A. High level of conservation in Plasmodium vivax merozoite surface protein 4 (PvMSP4). Infect. Genet. Evol. 5 (2005) 354-361
26. Mascorro C.N., Zhao K., Khuntirat B., Sattabongkot J., Yan G., Escalante A.A., and Cui L. Molecular evolution and intragenic recombination of the merozoite surface protein MSP-3□ from the malaria parasite Plasmodium vivax in Thailand. Parasitology 131 (2005) 25-35
27. Polson H.E., Conway D.J., Fandeur T., Mercereau-Puijalon O., and Longacre S. Gene polymorphism of Plasmodium falciparum merozoite surface proteins 4 and 5. Mol. Biochem. Parasitol. 142 (2005) 110-115
28. Price R.N., Tjitra E., Guerra C.A., Yeung S., White N.J., and Anstey N.M. Vivax malaria: neglected and not benign. Am. J. Trop. Med. Hyg. 77 6 Suppl. (2007) 79-87
29. Putaporntip C., Jongwutiwes S., Sakihama N., Ferreira M.U., Kho W.G., Kaneko A., Kanbara H., Hattori T., and Tanabe K. Mosaic organization and heterogeneity in frequency of allelic recombination of the Plasmodium vivax merozoite surface protein-1 locus. Proc. Natl. Acad. Sci. U.S.A. 99 (2002) 16348-16353
30. Putaporntip C., Jongwutiwes S., Tia T., Ferreira M.U., Kanbara H., and Tanabe K. Diversity in the thrombospondin-related adhesive protein gene (TRAP) of Plasmodium vivax. Gene 268 (2001) 97-104
31. Rayner J.C., Corredor V., Feldman D., Ingravallo P., Iderabdullah F., Galinski M.R., and Barnwell J.W. Extensive polymorphism in the Plasmodium vivax merozoite surface coat protein MSP-3α is limited to specific domains. Parasitology 125 (2002) 393-405
32. Rayner J.C., Huber C.S., Feldman D., Ingravallo P., Galinski M.R., and Barnwell J.W. Plasmodium vivax merozoite surface protein PvMSP-3 beta is radically polymorphic through mutation and large insertions and deletions. Infect. Genet. Evol. 4 (2004) 309-319
33. Richie T.L., and Saul A. Progress and challenges for malaria vaccines. Nature 415 (2002) 694-701
34. Roberts L., and Enserink M. Malaria. Did they really say eradication?. Science 318 (2007) 1544-1545
35. Rodriguez-Morales A.J., Benítez J.A., and Arria M. Malaria mortality in Venezuela: focus on deaths due to Plasmodium vivax in children. J. Trop. Pediatr. 54 (2008) 94-101
36. Rozas J., Sánchez-DelBarrio J.C., Messeguer X., and Rozas R. DnaSP, DNA polymorphism analyses by the coalescent and other methods. Bioinformatics 19 (2003) 2496-2497
37. Tamura K., Dudley J., Nei M., and Kumar S. MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol. Biol. Evol. 24 (2007) 1596-1599
38. Tjitra E., Anstey N.M., Sugiarto P., Warikar N., Kenangalem E., Karyana M., Lampah D.A., and Price R.N. Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia. PLoS Med. 5 (2008) e128
39. Wang L., Black C.G., Marshall V.M., and Coppel R.L. Structural and antigenic properties of merozoite surface protein 4 of Plasmodium falciparum. Infect. Immun. 67 (1999) 2193-2200
40. Wang L., Marshall V.M., and Coppel R.L. Limited polymorphism of the vaccine candidate merozoite surface protein 4 of Plasmodium falciparum. Mol. Biochem. Parasitol. 120 (2002) 301-303
41. Wang L., Richie T.L., Stowers A., Nhan D.H., and Coppel R.L. Naturally acquired antibody responses to Plasmodium falciparum merozoite surface protein 4 in a population living in an area of endemicity in Vietnam. Infect. Immun. 69 (2001) 4390-4397
42. Woodberry T., Minigo G., Piera K.A., Hanley J.C., de Silva H.D., Salwati E., Kenangalem E., Tjitra E., Coppel R.L., Price R.N., Anstey N.M., and Plebanski M. Antibodies to Plasmodium falciparum and Plasmodium vivax merozoite surface protein 5 in Indonesia: species-specific and cross-reactive responses. J. Infect. Dis. 198 (2008) 134-142